Meline David W
SEC CIK 1444612 · EDGAR
BoughtSold
Most active insiders at PACB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | HENRY CHRISTIAN O | See Remarks | — | $772.7K |
| 2 | Van Oene Mark | See Remarks | — | $335.1K |
| 3 | Gibson James R II | See Remarks | — | $120.8K |
| 4 | Farmer Michele | See Remarks | — | $84.5K |
| 5 | Gibson Christopher | Dir | — | — |
Meline David W made no open-market trades at PACB in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-20 | 2024-06-18 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Meline David W | Dir | A - Grant | $0.00 | +17.1K | 57.1K | +43% | $0 |
| 2024-04-24 | 2024-04-22 | HPQ | HP Inc. | Meline David W | Dir | A - Grant | $0.00 | +7,943 | 10.7K | +289% | $0 | |
| 2024-03-06 | 2024-03-06 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Meline David W | Dir | P - Purchase | $4.40 | +40.0K | 40.0K | New | +$176.0K | |
| 2023-11-03 | 2023-11-01 | HPQ | HP Inc. | Meline David W | Dir | A - Grant | $0.00 | +2,747 | 2,747 | New | $0 | |
| D | 2022-08-11 | 2022-08-10 | MRNA | Moderna | Meline David W | CFO | S - Sale+OE | $173.66 | -164 | 2,857 | -5% | -$28.5K |
| D | 2022-08-11 | 2022-08-09 | MRNA | Moderna | Meline David W | CFO | M - OptEx | $0.00 | +348 | 3,021 | +13% | $0 |
| D | 2022-05-11 | 2022-05-10 | MRNA | Moderna | Meline David W | CFO | S - Sale+OE | $133.71 | -156 | 2,583 | -6% | -$20.9K |
| D | 2022-05-11 | 2022-05-09 | MRNA | Moderna | Meline David W | CFO | M - OptEx | $134.40 | +348 | 2,739 | +15% | +$46.8K |
| D | 2022-02-11 | 2022-02-09 | MRNA | Moderna | Meline David W | CFO | M - OptEx | $0.00 | +1,392 | 3,010 | +86% | $0 |
| D | 2022-02-11 | 2022-02-10 | MRNA | Moderna | Meline David W | CFO | S - Sale+OE | $158.89 | -619 | 2,391 | -21% | -$98.4K |
Purchase Sale Sale after option exercise All abbreviations